Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rosemary Scerni is active.

Publication


Featured researches published by Rosemary Scerni.


Bioorganic & Medicinal Chemistry Letters | 2002

Studies toward the discovery of the next generation of antidepressants. Part 2: Incorporating a 5-HT1A antagonist component into a class of serotonin reuptake inhibitors

Richard Eric Mewshaw; Kristin Lynne Meagher; Ping Zhou; Dahui Zhou; Xiaojie Shi; Rosemary Scerni; Deborah H. Smith; Lee E. Schechter; Terrance H. Andree

The design and synthesis of a novel series of indole derivatives (9) having dual 5-HT transporter reuptake and 5-HT(1A) antagonist activity are described.


Bioorganic & Medicinal Chemistry Letters | 2001

Studies towards the next generation of antidepressants. Part 1: indolylcyclohexylamines as potent serotonin reuptake inhibitors

Kristin Lynne Meagher; Richard Eric Mewshaw; Deborah A. Evrard; Ping Zhou; Deborah L. Smith; Rosemary Scerni; Taylor Spangler; Susan Abulhawa; Xiaojie Shi; Lee E. Schechter; Terrance H. Andree

A series of indolylcyclohexylamines possessing potent and selective serotonin reuptake inhibition is reported. The most interesting compounds proved to have subnanomolar 5-HT transporter activity, and exhibited moderate 5-HT(1A) affinity.


Bioorganic & Medicinal Chemistry Letters | 2010

Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity

Aranapakam Mudumbai Venkatesan; O. Dos Santos; John W. Ellingboe; Deborah A. Evrard; Boyd L. Harrison; Deborah L. Smith; Rosemary Scerni; Geoffrey Hornby; Lee E. Schechter; Terrence H. Andree

Several benzofuran derivatives linked to a 3-indoletetrahydropyridine through an alkyl chain were prepared and evaluated for serotonin transporter and 5-HT(1A) receptor affinities. Their design, synthesis and structure-activity relationships are described.


Tetrahedron | 1998

New generation dopaminergic agents 4. Exploiting the 2-methyl chroman scaffold. Synthesis and evaluation of two novel series of 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano[2,3-e]indole and indol-8-one derivatives

Richard Eric Mewshaw; Karen L. Marquis; Xiaojie Shi; Georgia B. McGaughey; Gary Stack; Michael Byron Webb; Magid Abou-Gharbia; Theodore Wasik; Rosemary Scerni; Taylor Spangler; Hossein Mazandarani; Joseph Coupet; Terrance H. Andree

Abstract The rational design, synthesis, and evaluation of two novel series of 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano[2,3-e]indole and indolone derivatives are disclosed, based on the recently discovered D 2 agonist phenolic template prototype [i.e. the 7-OH-2-(aminomethyl)chroman nucleus]. The indolones were observed to have higher affinity and intrinsic activity than the corresponding indoles.


Journal of Medicinal Chemistry | 1999

Synthesis and SAR of adatanserin : Novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents

Magid Abou-Gharbia; Wayne E. Childers; Horace Fletcher; Georgia B. McGaughey; Usha R. Patel; Michael Byron Webb; John Patrick Yardley; Terrance H. Andree; Carl A. Boast; Robert J. Kucharik; Karen L. Marquis; Herman Morris; Rosemary Scerni; John A. Moyer


Journal of Medicinal Chemistry | 1997

New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans

Richard Eric Mewshaw; Joseph Kavanagh; Gary Paul Stack; Karen L. Marquis; Xiaojie Shi; Michael Z. Kagan; Michael Byron Webb; Alan H. Katz; Anna Park; Young Hee Kang; Magid Abou-Gharbia; Rosemary Scerni; Theodore Wasik; Luz Cortes-Burgos; Taylor Spangler; Michael Piesla; Hossein Mazandarani; Mark I. Cockett; Rafal Ochalski; Joseph Coupet; Terrance H. Andree


Journal of Medicinal Chemistry | 2004

Studies toward the Discovery of the Next Generation of Antidepressants. 3. Dual 5-HT1A and Serotonin Transporter Affinity within a Class of N-Aryloxyethylindolylalkylamines

Richard Eric Mewshaw; Dahui Zhou; Ping Zhou; Xiaojie Shi; Geoffrey Hornby; Taylor Spangler; Rosemary Scerni; Deborah F. Smith; Lee E. Schechter; Terrance H. Andree


Bioorganic & Medicinal Chemistry Letters | 2006

Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.

Dahui Zhou; Boyd L. Harrison; Uresh Shantilal Shah; Terrance H. Andree; Geoffrey Hornby; Rosemary Scerni; Lee E. Schechter; Deborah L. Smith; Kelly Sullivan; Richard Eric Mewshaw


Bioorganic & Medicinal Chemistry Letters | 2004

Modulation of selective serotonin reuptake inhibitor and 5-HT1A antagonist activity in 8-aza-bicyclo[3.2.1]octane derivatives of 2,3-dihydro-1,4-benzodioxane

Adam M. Gilbert; Gary Stack; Ramaswamy Nilakantan; Jason Kodah; Megan Tran; Rosemary Scerni; Xiaojie Shi; Deborah L. Smith; Terrance H. Andree


Bioorganic & Medicinal Chemistry Letters | 2004

Novel aryloxy-8-azabicyclo[3.2.1]oct-3-enes with 5-HT transporter and 5-HT1A affinity

Adam M. Gilbert; Thomas Coleman; Jason Kodah; Richard Eric Mewshaw; Rosemary Scerni; Lee E. Schechter; Deborah L. Smith; Terrance H. Andree

Collaboration


Dive into the Rosemary Scerni's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge